Goat Anti-Rabbit Alexa594
ThermoFisher Cat#A-11037 (Balthasar et al, 2004) were genotyped with the following primers:
5'-TGGCTCAATGTCCTTCCTGG-3' and 5'-GAAATCAGTGCGTTCGAACGCTAG A-3' The product size is about 580 bp. Expression level is measured as the natural log of the number of unique molecular identifier (UMI) transcript counts per gene, normalized by 10,000 counts per cell. X-axis denotes specific cell-type clusters (D), determined using Seurat v2.1's FindMarkers function, and a cell-specific marker threshold set at 70 counts per transcript 10,000 counts. Neuron-specific clusters (13 through 18) highlighted inside red boxes. Data are presented using Broad Institute Single Cell Portal (https://portals.broadinstitute.org/single_cell). For full study details, please see (27).
Supplemental Figure 7 . ICV administration of CDK4/6 inhibitor abemaciclib inhibited pRb phosphorylation in the MBH and reduced adipocyte hypertrophy. Two groups of weight and body composition matched male 10-week-old C57BL/6J mice were stereotaxically cannulated in the third ventricle. Daily injections for two weeks (Mon-Fri) consisted of 1 µL of 10 µM abemaciclib or artificial CSF (ACSF) as control. HFD was initiated concurrently with the first injection. (A) Representative MBH sections from animal brains harvested upon conclusion of icv study are stained with pRbS807p/S811p antibody for phosphorylated pRb. (B) H&E stained gonadal fat pad section from ACSF treated mice, showing marked adipocyte hypertrophy and abemaciclib treated mice, showing reduced adipocyte hypertrophy. n = 5 per group.
Supplemental Figure 8 . Abemaciclib treatment has no effect on the body composition of normal chow diet fed mice. (A) Two groups of weight and body composition matched male 9-week-old C57BL/6J mice were continuously gavaged with abemaciclib (60mg/kg) daily for 42 days. Body mass compositions of mice after 42 days of treatment were assessed by MRI. (B) Fat-mass measured bi-weekly as percent of total body mass.
Supplemental Figure 9 . Abemaciclib treatment reverses DIO-mediated heptaosteatosis. Two groups of weight and body composition matched male 9-week-old C57BL/6J mice were fed HFD for 4 weeks and matched into pairs based on similar bodymass composition for daily gavage with 60mg/kg abemaciclib or saline control concurrent with HFD. Shown are representative H&E stained liver sections after 21 days of treatment, showing reduced microvesicular fat accumulation in the hepatocytes of abemaciclib treated animals. scale bar = 100 µm. n = 6 per group. Figure 10 . Abemaciclib treatment reduces fat mass in DIO mice regardless of pre-treatment body composition. Two groups of weight and body composition matched male 9-week-old C57BL/6J mice were fed HFD for 4 weeks and matched into pairs based on similar body-mass composition for daily gavage with 60mg/kg abemaciclib or saline control concurrent with HFD. Body fat mass percents of individual animals were measured at indicated days during treatment. Similar line patterns indicate pre-treatment body-composition matched animal pairs. n = 6 per group.
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